Pozen, Inc. Says FDA Reviewing Main Goal of Trials
Oct 17 (Reuters) - Pozen Inc said U.S. health regulators are conducting an internal review on the acceptability of using endoscopic gastric ulcers as a main goal in clinical studies and it was unsure if the review will have any impact on its development programs.